T
Tamar Nijsten
Researcher at Erasmus University Rotterdam
Publications - 316
Citations - 10101
Tamar Nijsten is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 45, co-authored 280 publications receiving 8309 citations.
Papers
More filters
Journal ArticleDOI
The Rotterdam Study: Objectives and design update
Albert Hofman,Guy Brusselle,Sarwa Darwish Murad,Cornelia M. van Duijn,Oscar H. Franco,André Goedegebure,M. Arfan Ikram,Caroline C W Klaver,Tamar Nijsten,Robin P. Peeters,Bruno H. Ch. Stricker,Henning Tiemeier,André G. Uitterlinden,Meike W. Vernooij +13 more
TL;DR: The rationale of the study and its design is given, and a summary of the major findings and an update of the objectives and methods are presented.
Journal ArticleDOI
Markers of systemic inflammation in psoriasis: A systematic review and meta-analysis
TL;DR: The pooled analyses suggest modest but significantly elevated levels of the proinflammatory cytokines in the serum of patients with psoriasis with predominantly severe disease.
Journal ArticleDOI
Prevalence of actinic keratosis and its risk factors in the general population: The rotterdam study
S.C. Flohil,Robert van der Leest,Emmilia A. Dowlatshahi,Albert Hofman,Esther de Vries,Tamar Nijsten +5 more
TL;DR: Male gender, older age, light pigmentation status, severe baldness, skin wrinkling, and high tendency for sunburn were significantly associated with extensive actinic damage (≥ 10 AKs) in the multivariate analyses.
Journal ArticleDOI
Epidemiology of basal cell carcinoma: scholarly review.
TL;DR: To provide the most appropriate BCC care, physicians should engage in shared decision‐making and choose their treatments wisely.
Journal ArticleDOI
Psoriasis May Not be an Independent Risk Factor for Acute Ischemic Heart Disease Hospitalizations: Results of a Large Population-Based Dutch Cohort
TL;DR: Psoriasis is not a clinically relevant risk factor for ischemic heart disease hospitalizations on the population level, according to a cohort study conducted using hospital and pharmacy records of 2.5 million Dutch residents between 1997 and 2008.